CLOV vs PALI · rev $1.37B vs P/E 15, $316.3M cap
Clover Health Investments Corp (CLOV) versus Palisade Bio Inc (PALI) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PALI revenue for 2024-12-31 was $0. Net income was -$14.4M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
CLOV currently screens at market cap $1.55B. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
Not investment advice. Open the CLOV and PALI stock pages for the full models.
Not investment advice.